Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma - A Randomised Phase III Trial

NCT01503827 is registered in ClinicalTrials.gov with Melanoma and Skin Cancer Trials Limited as lead sponsor.

NCT NCT01503827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01503827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma - A Randomised Phase III Trial
Lead sponsor
Melanoma and Skin Cancer Trials Limited
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2007
Completion date
June 30, 2022
Enrollment
220 (estimated)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma